ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 954,48
1,85%
DAX
18 518,03
-0,44%
Brent Oil
83,315
-1,22%
Bitcoin
65 202,60
0,54%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
19/08/202014h00PR Newswire (Canada)Teva Canada announces product availability of AJOVY™NYSE:TEVATeva Pharmaceutical Industries Ltd
19/08/202014h00Business WireTeva Canada annonce la mise en marché d’AJOVYMCNYSE:TEVATeva Pharmaceutical Industries Ltd
19/08/202009h02Dow Jones NewsTeva's U.S. Unit Accused of Using Donations to Aid Drug Business -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
19/08/202009h02Dow Jones NewsStates Press Opioid Litigation -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
18/08/202020h48Dow Jones NewsProsecutors Sue Teva's U.S. Business Over Charitable Donations -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
18/08/202020h05Dow Jones NewsProsecutors Sue Teva's U.S. Business Over Charitable Donations -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
18/08/202020h03Dow Jones NewsProsecutors Sue Teva's U.S. Business Over Charitable DonationsNYSE:TEVATeva Pharmaceutical Industries Ltd
18/08/202019h39Dow Jones NewsJustice Department Alleges Teva Pharmaceutical's U.S. Business Violated Anti-Kickback LawNYSE:TEVATeva Pharmaceutical Industries Ltd
18/08/202011h59Dow Jones NewsStates Seek $26.4 Billion From Drug Companies in Opioid LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
17/08/202015h13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:TEVATeva Pharmaceutical Industries Ltd
14/08/202017h18Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:TEVATeva Pharmaceutical Industries Ltd
13/08/202022h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
06/08/202022h17Edgar (US Regulatory)Current Report Filing (8-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/202022h49Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/202022h44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/202022h06Edgar (US Regulatory)Quarterly Report (10-q)NYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/202013h10Business WireTeva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar MarketNYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/202013h00Business WireTeva Reports Second Quarter 2020 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
30/07/202008h00Business WireTeva Announces New Strategic Focus in the Japanese MarketNYSE:TEVATeva Pharmaceutical Industries Ltd
29/07/202014h00Business WireTeva Announces New Drug Application Filing in Japan for AJOVY® (fremanezumab) InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/202014h30GlobeNewswire Inc.Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial OfficerNYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/202014h00Business WireTeva Announces Availability of ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder for Patients with Asthma & ...NYSE:TEVATeva Pharmaceutical Industries Ltd
09/07/202022h00Business WireTeva to Host Conference Call to Discuss Second Quarter 2020 Financial Results at 8 a.m. ET on August 5, 2020NYSE:TEVATeva Pharmaceutical Industries Ltd
18/06/202014h00Business WireTeva Presents New Analyses Examining Changes in Migraine Disability Outcome Measurements with AJOVY® (fremanezumab-vfrm) Inj...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/06/202014h00Business WireTeva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection Open-Label Extension Study at American Headache Society Ann...NYSE:TEVATeva Pharmaceutical Industries Ltd
11/06/202013h17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:TEVATeva Pharmaceutical Industries Ltd
09/06/202013h30GlobeNewswire Inc.NIRI Philadelphia Elects New Board MembersNYSE:TEVATeva Pharmaceutical Industries Ltd
02/06/202014h00Business WireTeva Showcases Global Impact in 2019 Environmental, Social and Governance Progress ReportNYSE:TEVATeva Pharmaceutical Industries Ltd
26/05/202014h00Business WireTeva Announces Virtual 2020 Annual Meeting of ShareholdersNYSE:TEVATeva Pharmaceutical Industries Ltd
25/05/202019h08Business WireTeva präsentiert auf dem Kongress der Europäischen Akademie für Neurologie neue Daten zur Evaluierung der Erfahrungen von ...NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

BIT
UI329C
Unicredit Bank
NASDAQ
TRJLX
T Rowe Price Retirement ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés